WELLS FARGO & COMPANY/MN
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in SUPN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,329,452
+$1,216,877 QoQ
Shares Held
50,085
+132.7% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 335 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. SUPN ranks #24 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,278 | $130,014,715 | |
| 2 | HLN |
Haleon plc
|
4,924,330 | $45,943,997 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
253,026 | $42,644,999 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
74,303 | $40,259,592 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
976,361 | $24,028,242 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
559,389 | $19,394,014 | |
| 7 | VTRS |
Viatris Inc
|
1,175,495 | $18,666,859 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,150,820 | $18,447,643 |
All Filings in SUPN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,329,452 | 50,085 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,112,575 | 21,524 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,035,277 | 61,072 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,995,996 | 41,766 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,213,837 | 70,236 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,118,596 | 64,690 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,286,648 | 63,237 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,723,504 | 55,276 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,477,803 | 55,245 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,664,600 | 48,801 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,344,956 | 46,474 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,296,422 | 47,023 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,857,526 | 61,794 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,873,923 | 51,723 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,485,047 | 41,633 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,674,152 | 49,458 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,540,394 | 53,264 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,440,075 | 106,438 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,463,215 | 118,766 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,797,992 | 142,407 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,852,166 | 125,111 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,554,765 | 212,176 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,354,304 | 133,319 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,929,415 | 140,567 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $3,055,460 | 128,651 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,141,329 | 119,029 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||